Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of GlobeStar Therapeutics Corporation
No Price
Closing Price OTC 30.04.2026:
0,0001 USD
30.04.2026 20:00
Current Prices from GlobeStar Therapeutics Corporation
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
UTC
GSTC
USD
30.04.2026 20:00
0,0001 USD
0,00 USD
Company Profile for GlobeStar Therapeutics Corporation Share
GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. The company was incorporated in 2016 and is based in Richland, Washington.
